SCHEMBL2934110

SCHEMBL2934110

CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C=Cc2ccc(Cl)cc2)[C@H](N(C(=O)O)C(C)(C)C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.47
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 1/20 0.37
MAPT P10636 4/20 0.36
RECQL P46063 1/20 0.36
HDAC2 Q92769 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
MCHR1 Q99705 2/20 0.35
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
EGFR P00533 1/20 0.34
MMP1 P03956 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2934107 1.00 MAPK1 (0.47) MAPK1POLBL3MBTL1SMN1; SMN2HPGD
SCHEMBL1504207 0.82 MAPK1 (0.52) MAPK1POLBL3MBTL1SMN1; SMN2HPGD
SCHEMBL1504202 0.82 MAPK1 (0.52) MAPK1POLBL3MBTL1SMN1; SMN2HPGD
SCHEMBL12035790 0.82 MAPK1 (0.54) MAPK1POLBL3MBTL1SMN1; SMN2HPGD
SCHEMBL6362939 0.80 F10 (0.36) MAPTMEN1KMT2ANPC1LMNA
SCHEMBL4268500 0.79 MAPK1 (0.47) MAPK1POLBL3MBTL1SMN1; SMN2MAPT
SCHEMBL4268490 0.79 MAPK1 (0.47) MAPK1POLBL3MBTL1SMN1; SMN2MAPT
SCHEMBL6361764 0.78 F10 (0.32)
SCHEMBL6362834 0.77 TSHR (0.33) SMN1; SMN2MAPTRECQLMEN1KMT2A
SCHEMBL2940481 0.77 F10 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100093785-A1 DIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2010-04-15 US disclosed
US-20050119486-A1 Diamine derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093785-A1 DIAMINE DERIVATIVES C9, C1S, C1R MAPK1 1701/4885POLB 1264/4885L3MBTL1 309/4885
US-20050119486-A1 Diamine derivatives C9, C1S, C1R MAPK1 1864/4885POLB 868/4885L3MBTL1 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.